Arkolith/Insider Trading/ACRV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerAcrivon Therapeutics, Inc. (ACRV) · full profile →Form 4 · filed Apr 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 22, 2026Grant(A)3.9M$1.80$7.0M11.8M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000396) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML